LYNN THIBODEAU: Open Payments
NPI 1811992696 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,719 in 129 payments from 38 companies in 2025. Trend: 2023 $1,683 · 2024 $2,509 · 2025 $2,719
Food & beverage: $2,719
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $284 |
| Daiichi Sankyo Inc. | 14 | $246 |
| AstraZeneca Pharmaceuticals LP | 9 | $203 |
| GlaxoSmithKline, LLC. | 7 | $151 |
| Merck Sharp & Dohme LLC | 4 | $124 |
| Gilead Sciences, Inc. | 5 | $102 |
| Astellas Pharma US Inc | 5 | $99 |
| Immunocore Limited | 4 | $96 |
| GENZYME CORPORATION | 4 | $85 |
| Exelixis Inc. | 4 | $85 |
Products named: Enhertu, Fabhalta, KEYTRUDA, EPKINLY, IMFINZI, Trodelvy, KIMMTRAK, CABOMETYX.
Industry payments across FL — which companies pay providers there.
